<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A reverse phase protein microarray approach has been applied to quantify proteins of energy metabolism in <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biopsies of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients </plain></SENT>
<SENT sid="1" pm="."><plain>The metabolic proteome of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens revealed a profound shift towards and enhanced glycolytic phenotype and concurrent <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> alteration </plain></SENT>
<SENT sid="2" pm="."><plain>The metabolic signature discriminated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with highly significant differences in overall and disease-free prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>The quantification of the bioenergetic signature of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> offers a relevant biomarker of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> that could contribute in the handling of these patients </plain></SENT>
</text></document>